Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary E Gallick

Showing results (51-60 of 114) with videos related to

Pageof 12
Sort By:
International Journal of Oncology|June 15, 2006
Inhibition of PDGFR phosphorylation and Src and Akt activity by GN963 leads to therapy of human pancreatic cancer growing orthotopically in nude miceCheryl H Baker, Jose G Trevino, Justin M Summy, et al.
Molecular Cancer|April 18, 2015
The transcription factors Ik-1 and MZF1 downregulate IGF-IR expression in NPM-ALK⁺ T-cell lymphomaDeeksha Vishwamitra, Choladda V Curry, Serhan Alkan, et al.
Cancer Research|May 4, 2005
Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptorsMichael J Gray, Jane S Wey, Anna Belcheva, et al.
Cancer Research|August 3, 2005
CXCL-12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activationNeslihan Cabioglu, Justin Summy, Claudia Miller, et al.
Cancer Research|March 12, 2009
Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathwayZhiwei Wang, Yiwei Li, Dejuan Kong, et al.
Molecular Cancer Therapeutics|August 8, 2006
Regulatory role of c-Met in insulin-like growth factor-I receptor-mediated migration and invasion of human pancreatic carcinoma cellsTodd W Bauer, Ray J Somcio, Fan Fan, et al.
Plos One|June 23, 2011
ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinomaMichael P Kim, Jason B Fleming, Huamin Wang, et al.
Journal of Geriatric Oncology|February 24, 2019
Potentially inappropriate medications defined by STOPP criteria in older patients with breast and colorectal cancerMeghan S Karuturi, Holly M Holmes, Xiudong Lei, et al.
Head & Neck|June 5, 2013
Src inhibitors in suppression of papillary thyroid carcinoma growthYing C Henderson, Rafael Toro-Serra, Yunyun Chen, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 16, 2002
Impact of insulin-like growth factor receptor-I function on angiogenesis, growth, and metastasis of colon cancerNiels Reinmuth, Fan Fan, Wenbiao Liu, et al.
Pageof 12

Showing results (51-60 of 114) with videos related to

Sort By:
Pageof 12
International Journal of Oncology|June 15, 2006
Inhibition of PDGFR phosphorylation and Src and Akt activity by GN963 leads to therapy of human pancreatic cancer growing orthotopically in nude miceCheryl H Baker, Jose G Trevino, Justin M Summy, et al.
Molecular Cancer|April 18, 2015
The transcription factors Ik-1 and MZF1 downregulate IGF-IR expression in NPM-ALK⁺ T-cell lymphomaDeeksha Vishwamitra, Choladda V Curry, Serhan Alkan, et al.
Cancer Research|May 4, 2005
Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptorsMichael J Gray, Jane S Wey, Anna Belcheva, et al.
Cancer Research|August 3, 2005
CXCL-12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activationNeslihan Cabioglu, Justin Summy, Claudia Miller, et al.
Cancer Research|March 12, 2009
Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathwayZhiwei Wang, Yiwei Li, Dejuan Kong, et al.
Molecular Cancer Therapeutics|August 8, 2006
Regulatory role of c-Met in insulin-like growth factor-I receptor-mediated migration and invasion of human pancreatic carcinoma cellsTodd W Bauer, Ray J Somcio, Fan Fan, et al.
Plos One|June 23, 2011
ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinomaMichael P Kim, Jason B Fleming, Huamin Wang, et al.
Journal of Geriatric Oncology|February 24, 2019
Potentially inappropriate medications defined by STOPP criteria in older patients with breast and colorectal cancerMeghan S Karuturi, Holly M Holmes, Xiudong Lei, et al.
Head & Neck|June 5, 2013
Src inhibitors in suppression of papillary thyroid carcinoma growthYing C Henderson, Rafael Toro-Serra, Yunyun Chen, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 16, 2002
Impact of insulin-like growth factor receptor-I function on angiogenesis, growth, and metastasis of colon cancerNiels Reinmuth, Fan Fan, Wenbiao Liu, et al.
Pageof 12